IV Ketorolac Preparations
Intravenous ketorolac (Toradol) is available in two concentrations: 15 mg/mL and 30 mg/mL in single-dose vials, supplied as sterile solutions containing 10% alcohol and sodium chloride. 1
Available Formulations
The FDA-approved IV ketorolac preparations include:
- 15 mg in 1 mL (1.5% concentration)
- 30 mg in 1 mL (3% concentration) - approved for both IV and IM use
- 60 mg in 2 mL (3% concentration) - approved for IM administration only 1
All solutions are clear, slightly yellow in color, with a pH range of 6.9 to 7.9, adjusted with sodium hydroxide and/or hydrochloric acid. Each formulation contains 10% (w/v) alcohol USP and varying amounts of sodium chloride (6.68 mg, 4.35 mg, and 8.70 mg respectively) in sterile water. 1
Practical Considerations for Administration
The 30 mg/mL single-dose vial is the most commonly stocked preparation for IV/IM use in clinical practice. 1 This concentration allows for flexible dosing based on current evidence suggesting lower doses may be equally effective.
Compatibility and Stability
Ketorolac demonstrates excellent stability when mixed with common IV solutions including:
- 0.9% sodium chloride
- 5% dextrose
- Lactated Ringer's
- Plasma-Lyte A
The drug shows no degradation, particulate formation, or adsorption to PVC bags, glass bottles, or administration tubing for up to 48 hours at room temperature. 2 Standard admixture concentrations of 30 mg/50 mL are stable across all tested solutions.
Dosing Context
While the question asks specifically about preparations, it's clinically relevant that recent evidence supports using lower doses (10-15 mg IV) rather than the traditional 30 mg dose for acute pain management, as these provide equivalent analgesia with potentially fewer adverse effects. 3, 4 The available 30 mg/mL concentration allows for precise administration of these lower doses.